MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
17.25
+0.20
+1.17%
After Hours: 17.26 +0.01 +0.06% 17:02 09/09 EDT
OPEN
17.27
PREV CLOSE
17.05
HIGH
17.36
LOW
17.08
VOLUME
1.47M
TURNOVER
--
52 WEEK HIGH
19.26
52 WEEK LOW
9.49
MARKET CAP
5.51B
P/E (TTM)
36.00
1D
5D
1M
3M
1Y
5Y
1D
Amneal Pharmaceuticals Price Target Announced at $23.00/Share by Leerink Partners
Dow Jones · 6h ago
Leerink Partners Initiates Coverage On Amneal Pharmaceuticals with Outperform Rating, Announces Price Target of $23
Benzinga · 7h ago
Leerink bullish on Amneal Pharmaceuticals, initiates with an Outperform
TipRanks · 9h ago
Amneal Pharmaceuticals initiated with an Outperform at Leerink
TipRanks · 11h ago
How Investors May Respond To Amneal Pharmaceuticals (AMRX) Shelf Share Filing
Simply Wall St · 1d ago
Weekly Report: what happened at AMRX last week (0831-0904)?
Weekly Report · 2d ago
Does Amneal’s New US$523 Million Shelf Registration Reframe Its Capital Allocation Story for AMRX?
Simply Wall St · 2d ago
Amneal Pharmaceuticals (AMRX) Following Its Biosimilars Push And The Fair Value Debate
Simply Wall St · 5d ago
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.